289 related articles for article (PubMed ID: 23587221)
1. Antiviral activity of stachyflin on influenza A viruses of different hemagglutinin subtypes.
Motohashi Y; Igarashi M; Okamatsu M; Noshi T; Sakoda Y; Yamamoto N; Ito K; Yoshida R; Kida H
Virol J; 2013 Apr; 10():118. PubMed ID: 23587221
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel HA conformational change inhibitor of human influenza virus.
Yoshimoto J; Kakui M; Iwasaki H; Fujiwara T; Sugimoto H; Hattori N
Arch Virol; 1999; 144(5):865-78. PubMed ID: 10416371
[TBL] [Abstract][Full Text] [Related]
3. Identification of amino acids of influenza virus HA responsible for resistance to a fusion inhibitor, Stachyflin.
Yoshimoto J; Kakui M; Iwasaki H; Sugimoto H; Fujiwara T; Hattori N
Microbiol Immunol; 2000; 44(8):677-85. PubMed ID: 11021398
[TBL] [Abstract][Full Text] [Related]
4. Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.
Marjuki H; Mishin VP; Chai N; Tan MW; Newton EM; Tegeris J; Erlandson K; Willis M; Jones J; Davis T; Stevens J; Gubareva LV
J Virol; 2016 Dec; 90(23):10446-10458. PubMed ID: 27630240
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
6. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
7.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutinins of Avian Influenza Viruses Are Proteolytically Activated by TMPRSS2 in Human and Murine Airway Cells.
Bestle D; Limburg H; Kruhl D; Harbig A; Stein DA; Moulton H; Matrosovich M; Abdelwhab EM; Stech J; Böttcher-Friebertshäuser E
J Virol; 2021 Sep; 95(20):e0090621. PubMed ID: 34319155
[TBL] [Abstract][Full Text] [Related]
9. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
10. Insights into structural and inhibitory mechanisms of low pH-induced conformational change of influenza HA2 protein: a computational approach.
Kannan S; Shankar R; Kolandaivel P
J Mol Model; 2019 Mar; 25(4):99. PubMed ID: 30904969
[TBL] [Abstract][Full Text] [Related]
11. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
12. Development of anti-influenza virus drugs I: improvement of oral absorption and in vivo anti-influenza activity of Stachyflin and its derivatives.
Yagi S; Ono J; Yoshimoto J; Sugita K; Hattori N; Fujioka T; Fujiwara T; Sugimoto H; Hirano K; Hashimoto N
Pharm Res; 1999 Jul; 16(7):1041-6. PubMed ID: 10450928
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
[TBL] [Abstract][Full Text] [Related]
14. 3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo.
Zhao X; Zhao L; Zhao Y; Huang K; Gong W; Yang Y; Zhao L; Xia X; Li Z; Sheng F; Du X; Jin M
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452298
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin.
Vanderlinden E; Göktas F; Cesur Z; Froeyen M; Reed ML; Russell CJ; Cesur N; Naesens L
J Virol; 2010 May; 84(9):4277-88. PubMed ID: 20181685
[TBL] [Abstract][Full Text] [Related]
16. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
17. Hemagglutinin stalk-based monoclonal antibody elicits broadly reactivity against group 1 influenza A virus.
Huang J; Huang N; Fan M; Zhao L; Luo Y; Ding P; Tian M; Liu Q; Guo Y; Zhao J; Zheng Y; Zhang H; Ping J
Virol J; 2020 Dec; 17(1):191. PubMed ID: 33287849
[TBL] [Abstract][Full Text] [Related]
18. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
19. An oligothiophene compound neutralized influenza A viruses by interfering with hemagglutinin.
Shen X; Zhu Z; Ding Y; Wu W; Yang J; Liu S
Biochim Biophys Acta Biomembr; 2018 Mar; 1860(3):784-791. PubMed ID: 29229526
[TBL] [Abstract][Full Text] [Related]
20. In vivo anti-influenza virus activity of kampo (Japanese herbal) medicine "sho-seiryu-to" and its mode of action.
Nagai T; Yamada H
Int J Immunopharmacol; 1994 Aug; 16(8):605-13. PubMed ID: 7527377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
